1. Home
  2. ZTS vs RMD Comparison

ZTS vs RMD Comparison

Compare ZTS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$73.70

Market Cap

32.5B

Sector

Health Care

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$223.91

Market Cap

28.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZTS
RMD
Founded
1952
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.5B
28.4B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
ZTS
RMD
Price
$73.70
$223.91
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$154.18
$292.56
AVG Volume (30 Days)
5.8M
1.4M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
1.86%
1.13%
EPS Growth
10.05
9.67
EPS
3.08
10.43
Revenue
$9,467,000,000.00
$2,957,013,000.00
Revenue This Year
$5.63
$10.60
Revenue Next Year
$4.77
$7.41
P/E Ratio
$24.62
$29.10
Revenue Growth
2.28
13.44
52 Week Low
$71.45
$180.27
52 Week High
$160.48
$293.81

Technical Indicators

Market Signals
Indicator
ZTS
RMD
Relative Strength Index (RSI) 45.19 61.36
Support Level $73.42 $218.39
Resistance Level $78.74 $233.75
Average True Range (ATR) 3.08 7.14
MACD -0.06 1.23
Stochastic Oscillator 28.33 85.77

Price Performance

Historical Comparison
ZTS
RMD

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: